| Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia J Horacek, V Bubenikova-Valesova, M Kopecek, T Palenicek, C Dockery, ... CNS drugs 20, 389-409, 2006 | 615 | 2006 |
| Updated European Consensus Statement on diagnosis and treatment of adult ADHD JJS Kooij, D Bijlenga, L Salerno, R Jaeschke, I Bitter, J Balazs, J Thome, ... European psychiatry 56 (1), 14-34, 2019 | 570 | 2019 |
| Association Between Catechol O-Methyltransferase Genotype and Violence in Schizophrenia and Schizoaffective Disorder HM Lachman, KA Nolan, P Mohr, T Saito, J Volavka American Journal of Psychiatry 155 (6), 835-837, 1998 | 336 | 1998 |
| Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys P Winkler, T Formanek, K Mlada, A Kagstrom, Z Mohrova, P Mohr, ... Epidemiology and psychiatric sciences 29, e173, 2020 | 225 | 2020 |
| Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorder KA Nolan, J Volavka, P Mohr, P Czobor Psychiatric services 50 (6), 787-792, 1999 | 189 | 1999 |
| Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study RS Kahn, IW van Rossum, S Leucht, P McGuire, SW Lewis, M Leboyer, ... The Lancet Psychiatry 5 (10), 797-807, 2018 | 177 | 2018 |
| DSM-5®: diagnostický a statistický manuál duševních poruch J Raboch, M Hrdlička, P Mohr, P Pavlovský, R Ptáček Praha: Hogrefe-Testcentrum, 2015 | 151 | 2015 |
| Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations J Horacek, M Brunovsky, T Novak, L Skrdlantova, M Klirova, ... Neuropsychobiology 55 (3-4), 132-142, 2007 | 142 | 2007 |
| The double-blind sham-controlled study of high-frequency rTMS (20Hz) for negative symptoms in schizophrenia: negative results T Novak, J Horacek, P Mohr, M Kopecek, L Skrdlantova, M Klirova, ... Neuroendocrinology Letters 27 (1-2), 209-213, 2006 | 116 | 2006 |
| Vitamin D in anxiety and affective disorders M Bicikova, M Duskova, J Vitku, B Kalvachová, D Ripova, P Mohr, ... Physiological research 64, S101, 2015 | 110 | 2015 |
| White matter changes in first episode psychosis and their relation to the size of sample studied: a DTI study T Melicher, J Horacek, J Hlinka, F Spaniel, J Tintera, I Ibrahim, P Mikolas, ... Schizophrenia research 162 (1-3), 22-28, 2015 | 86 | 2015 |
| Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study F Španiel, JAN HrdliCKa, T Novák, J KOŽENÝ, C Höschl, P Mohr, ... Journal of Psychiatric Practice® 18 (4), 269-280, 2012 | 83 | 2012 |
| Prevalence of current mental disorders before and during the second wave of COVID-19 pandemic: An analysis of repeated nationwide cross-sectional surveys P Winkler, Z Mohrova, K Mlada, M Kuklova, A Kagstrom, P Mohr, ... Journal of psychiatric research 139, 167-171, 2021 | 81 | 2021 |
| Treatment of acute agitation in psychotic disorders P Mohr, J Pecenák, J Svestka, D Swingler, T Treuer Neuro Endocrinol Lett 26 (4), 327-35, 2005 | 77 | 2005 |
| Experience of stigma and discrimination reported by people experiencing the first episode of schizophrenia and those with a first episode of depression: the FEDORA project EA Corker, A Beldie, C Brain, M Jakovljevic, M Jarema, ... International Journal of Social Psychiatry 61 (5), 438-445, 2015 | 67 | 2015 |
| Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy. M Klirova, T Novak, M Kopecek, P Mohr, V Strunzova Neuro endocrinology letters 29 (1), 69-70, 2008 | 67 | 2008 |
| The application of vagus nerve stimulation and deep brain stimulation in depression P Mohr, M Rodriguez, A Slavíčková, J Hanka Neuropsychobiology 64 (3), 170-181, 2011 | 61 | 2011 |
| Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia M Bicikova, M Hill, D Ripova, P Mohr, R Hampl The Journal of steroid biochemistry and molecular biology 133, 77-83, 2013 | 60 | 2013 |
| Neuro-and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics M Bicikova, R Hampl, M Hill, D Ripova, P Mohr, Z Putz Neuroendocrinology letters 32 (2), 141-147, 2011 | 56 | 2011 |
| Long‐acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients P Mohr, P Knytl, V Voráčková, A Bravermanová, T Melicher International journal of clinical practice 71 (9), e12997, 2017 | 54 | 2017 |
